Treatment of graft-versus-host disease with mesenchymal cells as a complication of a liver transplantation. Scientific Publication

Nov 1, 2018 | Magazine: Revista Española de Enfermedades Digestivas

Lorena Mora 1 , Félix Alegre 2 , José Juan Rifón 3 , Pablo Martí 4 , José Ignacio Herrero 2

Abstract

We present the case of a liver transplant (LT) recipient donor who developed graft versus host disease (GVHD). The main features were cutaneous rash, diarrhea and pancytopenia.

Mesenchymal cells were administered as part of the treatment. This is the first case of a patient with GVHD after LT reported to date.

Despite the treatment, there was no improvement in aplasia or gastrointestinal symptoms and the patient died due to a disseminated infection.

CITATION Rev Esp Enferm Dig. 2018 Nov;110(11):734-736. doi: 10.17235/reed.2018.5672/2018.

see publication in pubmed